Clinical features of patients
| Feature . | Value . |
|---|---|
| Diagnosis, n | |
| MF | 42 |
| Sézary syndrome* | 1 |
| Clinical characteristics | |
| Age, median (range), y | 67 (26-86) |
| Died | 6 (14) |
| Erythrodermic | 3 (6) |
| Patch-stage lesions | 4 (8) |
| Plaque-stage lesions | 21 (42) |
| Tumor-stage lesions | 19 (38) |
| Normal skin | 2 (4) |
| SCC (excluded) | 1 (2) |
| Pathological characteristics | |
| Large cell | 14 (33) |
| CD8 phenotype | 1 (2) |
| Ki67, median (range), % | 31 (0-100) |
| Folliculotropic | 21 (49) |
| Stage, n | |
| IA | 7 |
| IB | 17 |
| IIA | 1 |
| IIB | 14 |
| IIIA | 1 |
| IVA1 | 1 |
| IVA2 | 2 |
| Feature . | Value . |
|---|---|
| Diagnosis, n | |
| MF | 42 |
| Sézary syndrome* | 1 |
| Clinical characteristics | |
| Age, median (range), y | 67 (26-86) |
| Died | 6 (14) |
| Erythrodermic | 3 (6) |
| Patch-stage lesions | 4 (8) |
| Plaque-stage lesions | 21 (42) |
| Tumor-stage lesions | 19 (38) |
| Normal skin | 2 (4) |
| SCC (excluded) | 1 (2) |
| Pathological characteristics | |
| Large cell | 14 (33) |
| CD8 phenotype | 1 (2) |
| Ki67, median (range), % | 31 (0-100) |
| Folliculotropic | 21 (49) |
| Stage, n | |
| IA | 7 |
| IB | 17 |
| IIA | 1 |
| IIB | 14 |
| IIIA | 1 |
| IVA1 | 1 |
| IVA2 | 2 |
Unless otherwise noted, data are n (%).
SCC, squamous cell carcinoma.
With tumors showing large cell transformation.